Neurology
From the Journals
Blood Tests for Alzheimer’s Are Here... Are Clinicians Ready?
An expert workgroup recommends two implementation pathways for Alzheimer’s disease blood biomarkers — one for current use for triaging and another...
News
FDA OKs Novel Levodopa-Based Continuous Sub-Q Regimen for Parkinson’s Disease
This new, non-surgical regimen provides continuous delivery of levodopa morning, day, and night.
Guidelines
ASA Releases New Primary Stroke Prevention Guideline
The updated guideline calls for better primary stroke prevention that includes improved screening and lifestyle changes.
From the Journals
AHA Scientific Statement Links Three Common Cardiovascular Diseases to Cognitive Decline, Dementia
Compelling evidence of the inextricable link between heart health and brain health underscores the benefit of early intervention.
From the Journals
White Matter Shows Decline After Bipolar Diagnosis
No significant differences appeared in the trajectories of cortical gray matter volume or thickness, hippocampal volume, or brain aging in adults...
Latest News
Long-Term Cognitive Monitoring Warranted After First Stroke
Stroke was associated with a significant acute decline in global cognition and a small, but significant, acceleration in the rate of cognitive...
From the Journals
Erenumab Reduces Nonopioid Medication Overuse Headache in Chronic Migraine
A prospective, double-blind, randomized, placebo-controlled trial showed that patients with chronic migraine and nonopioid medication overuse...
Latest News
High Cadmium Level Associated With Cognitive Impairment Risk
High levels of urinary cadmium were associated with double the risk of developing global cognitive impairment in White adults.
Conference Coverage
Autonomy Versus Safety in Cognitive Impairment Decision-Making
As healthcare systems across Europe deal with an increasing prevalence of cognitive impairment, family doctors are...
Commentary
Alzheimer’s and Comorbidities: Implications for Patient Care
A holistic assessment strategy that prioritizes early detection and management of comorbid conditions to mitigate their impact on AD progression...
Conference Coverage
Undertreatment of Women With MS Unjustified
“We believe that pregnancy-related considerations probably still explain the major part of this gap.”